Paragon Capital Management Inc Maravai Lifesciences Holdings, Inc. Transaction History

Paragon Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 26, 2024	SELL	$6.87 - $11.34 $141,432 - $233,456	-20,587 Closed	0 $0
Q1 2024 Sep 26, 2024	SELL	$5.11 - $8.76 $1.21 Million - $2.08 Million	-237,640 Reduced 92.03%	20,587 $178 Million
Q4 2023 Sep 26, 2024	BUY	$4.7 - $9.87 $653,647 - $1.37 Million	139,074 Added 116.72%	258,227 $1.69 Billion
Q3 2023 Sep 26, 2024	BUY	$9.14 - $12.85 $243,233 - $341,964	26,612 Added 28.76%	119,153 $1.19 Billion
Q2 2023 Sep 26, 2024	BUY	$12.09 - $15.0 $1.12 Million - $1.39 Million	92,541 New	92,541 $1.15 Billion

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $701M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Paragon Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Paragon Capital Management Inc with notifications on news.